$Cingulate (CING.US)$ Relevant Stats and Information: Net In...

Relevant Stats and Information:

Net Income: -3.21M +50% yoy

Net Cash 380K +9% yoy

FCF: -1.8M +60% yoy

Total debt: 333k -95% yoy

Current liability: 2.04M -81.96% yoy

No long term liability

Phase 3 completed for CTx-1301, NDA accepted by FDA. NDA acceptance to commercialization takes approximately 6-12 months or more, depending on scale up.

They have Phase 3 going for a generic Adderall equivalent

They've received approval from FDA and filed for a patent for their PTR tech, which allows for multiple doses in a single pill with EBL (erosion barrier layering) for precise dosing, eliminating need for "boosters"

Currently 60% of ADHD and equivalent patience take supplement IR medication boosters. ( including myself )

Overall, they spend 3.92M on R&D, which tells me they can scale that back to cover short term costs if they need.

My opinion is to wait until initial volatility subsides before buying, due to the length of time before they can begin generating revenue. They don't seem at risk of bankruptcy, with no LT debt, and equity and spending they can reduce or raise if they need.

I want in, and maybe this pop and drop is the time, but I'm growing more cautious as Sept. approaches. In addition, I set price alert for them and hundreds of others, so .y options have increased day to day.